IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform
In News
Salt Lake City, UT, June 23, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Presents Lung Cancer Trial Results at ATS 2022
In News
Salt Lake City, UT, May 19, 2022 – IONIQ Sciences is proud of our team members who...
Read More
IONIQ hosts Salt Lake City Mayor Mendenhall at its Office
In News
Salt Lake City, UT, May 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) was honored...
Read More
IONIQ Sciences hires Edison Group as Investor Relations Advisor
In News
Salt Lake City, UT, March 17, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today...
Read More
IONIQ Sciences announces IP acquisition and License buyout
In News
Salt Lake City, UT, March 8, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ’s breast cancer feasibility results published by IEEE
In News
Salt Lake City, UT, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ...
Read More
IONIQ Sciences announces Aaron B. Dorny has joined its Board of Directors
In News
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors Salt Lake...
Read More
IONIQ Sciences Announces Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee
In News
Salt Lake City, UT, September 23, 2021 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences Awarded Patent by Canadian Intellectual Property Office
In News
IONIQ Sciences has received a new Canadian Patent to add to our robust, growing intellectual...
Read More
Aetna Expands Coverage for Annual Low-Dose CT Scans Based on Updated USPSTF Guidelines
In News
In March 2021, we shared the news that the US Preventative Services Task Force (USPSTF)...
Read More